Holocene Advisors LP Has $5.16 Million Stake in Genpact Limited (NYSE:G)

Holocene Advisors LP reduced its stake in shares of Genpact Limited (NYSE:G - Free Report) by 17.9% during the 3rd quarter, according to its most recent 13F filing with the SEC. The institutional investor owned 131,478 shares of the business services provider's stock after selling 28,634 shares during the period. Holocene Advisors LP owned approximately 0.07% of Genpact worth $5,155,000 at the end of the most recent reporting period.

Several other large investors also recently bought and sold shares of the company. Jensen Investment Management Inc. lifted its position in Genpact by 6.4% in the 3rd quarter. Jensen Investment Management Inc. now owns 189,985 shares of the business services provider's stock valued at $7,449,000 after purchasing an additional 11,410 shares during the last quarter. Vanguard Personalized Indexing Management LLC grew its position in Genpact by 53.1% in the second quarter. Vanguard Personalized Indexing Management LLC now owns 49,134 shares of the business services provider's stock worth $1,580,000 after acquiring an additional 17,034 shares in the last quarter. Nisa Investment Advisors LLC lifted its stake in shares of Genpact by 329.6% in the second quarter. Nisa Investment Advisors LLC now owns 10,525 shares of the business services provider's stock worth $339,000 after buying an additional 8,075 shares during the last quarter. Access Investment Management LLC lifted its stake in shares of Genpact by 44.0% in the third quarter. Access Investment Management LLC now owns 212,875 shares of the business services provider's stock worth $8,347,000 after buying an additional 65,070 shares during the last quarter. Finally, Retirement Systems of Alabama raised its stake in Genpact by 1.7% during the 2nd quarter. Retirement Systems of Alabama now owns 449,845 shares of the business services provider's stock valued at $14,481,000 after purchasing an additional 7,645 shares during the last quarter. Institutional investors and hedge funds own 96.03% of the company's stock.

Insider Buying and Selling at Genpact

In other Genpact news, CEO Balkrishan Kalra sold 9,000 shares of the stock in a transaction that occurred on Monday, November 25th. The shares were sold at an average price of $46.40, for a total value of $417,600.00. Following the completion of the sale, the chief executive officer now owns 267,404 shares in the company, valued at $12,407,545.60. This represents a 3.26 % decrease in their position. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available through this hyperlink. 2.80% of the stock is currently owned by corporate insiders.

Analyst Upgrades and Downgrades

G has been the topic of a number of analyst reports. Robert W. Baird increased their price target on shares of Genpact from $44.00 to $48.00 and gave the company a "neutral" rating in a research report on Friday, November 8th. Needham & Company LLC lifted their target price on Genpact from $42.00 to $55.00 and gave the stock a "buy" rating in a report on Monday, November 11th. Jefferies Financial Group boosted their price target on Genpact from $35.00 to $40.00 and gave the company a "hold" rating in a research note on Monday, September 9th. BMO Capital Markets lifted their target price on Genpact from $38.00 to $42.00 and gave the company a "market perform" rating in a research report on Monday, August 12th. Finally, JPMorgan Chase & Co. upped their target price on Genpact from $35.00 to $43.00 and gave the company a "neutral" rating in a report on Friday, September 6th. Eight analysts have rated the stock with a hold rating and two have given a buy rating to the company's stock. According to data from MarketBeat.com, the stock presently has a consensus rating of "Hold" and a consensus price target of $42.33.

Genpact Stock Performance

Shares of G traded down $0.23 during mid-day trading on Thursday, hitting $45.26. 1,539,022 shares of the company's stock were exchanged, compared to its average volume of 1,347,128. Genpact Limited has a fifty-two week low of $30.23 and a fifty-two week high of $47.98. The business's 50 day moving average is $41.58 and its two-hundred day moving average is $37.24. The firm has a market capitalization of $7.98 billion, a P/E ratio of 12.50, a P/E/G ratio of 1.58 and a beta of 1.18. The company has a current ratio of 1.85, a quick ratio of 1.85 and a debt-to-equity ratio of 0.50.

Genpact Dividend Announcement

The firm also recently declared a quarterly dividend, which will be paid on Monday, December 23rd. Investors of record on Monday, December 9th will be given a dividend of $0.1525 per share. The ex-dividend date of this dividend is Monday, December 9th. This represents a $0.61 dividend on an annualized basis and a yield of 1.35%. Genpact's dividend payout ratio (DPR) is 16.76%.

Genpact Profile

Genpact Limited provides business process outsourcing and information technology services in India, rest of Asia, North and Latin America, and Europe. It operates through three segments: Financial services; Consumer and Healthcare; and High Tech and Manufacturing. The Financial Services segment offers retail customer onboarding, customer service, collections, card servicing operations, loan and payment operations, commercial loan, equipment and auto loan, mortgage origination, compliance services, reporting and monitoring, and wealth management operations support; financial crime and risk management services; and underwriting support, new business processing, policy administration, claims management, catastrophe modeling and actuarial services, as well as property and casualty claims.